Funding Rounds
MiroBio

MiroBio Series B (2022, $97M)

MiroBio

Platform focused on utilizing the body's natural immune control mechanisms.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series B

Raised Amount: $97.04M

Raised Date: 2022-01-01

Investors